PROVO, Utah and WOKING, England, Feb. 27, 2020 /PRNewswire/ — Axcend® today announced it has signed a worldwide Integration and Joint Marketing and Sales Agreement with Microsaic Systems (AIM:MSYS).
Under terms of the agreement, Axcend and Microsaic will work closely to integrate their respective scientific instruments into tightly coupled, compact, easy-to-use and cost-competitive liquid chromatography/mass spectrometry solutions. Combination LC/MS systems are highly valued by scientists and chemists around the world. Through this agreement, Axcend and Microsaic will work jointly and separately to market and sell their integrated LC/MS solutions globally.
“We have an award-winning, lightweight yet powerful HPLC that is easy-to-use and cost-competitive, especially on an operational basis,” said Glen Mella, CEO and Co-Founder of Axcend. “Yet many scientists need the added benefit of an LC/MS system to produce greater analytical insights. We’re confident that Microsaic will be an excellent partner for delivering compelling solutions to our customers.”
Axcend’s and Microsaic’s Products
The Axcend Focus LC® utilizes 150mm internal diameter capillary columns and single or dual UV-absorption detectors in compact, easily swappable cartridges to deliver reliable and fast HPLC detection and analytical outcomes. The Axcend Focus LC requires dramatically less solvent (under 10mL per week of continuous use) and produces significantly less waste, generating huge cost-savings versus traditional HPLC systems. Additionally, its small footprint and the ability to operate it in wireless, battery-powered environments allow it to be used nearly anywhere; from on a laboratory bench to inside a glove box, as well as in the field.
Microsaic has developed powerful, chip-based, benchtop and point-of-need mass spectrometry instruments that are designed to deliver processing and manufacturing agility, as well as commercial productivity, to the pharmaceutical and biopharmaceutical industries. Its core product — the 4500 MiD®— is a robust and compact MS systems that retains the functionality of larger conventional mass spectrometry instruments but is easier to use by non-specialists, consumes significantly less energy and has lower running costs.
“We are particularly excited by this partnership which not only combines incredibly compact products in one very powerful system, but also leverages our shared resources for marketing, sales and distribution channels on a global basis,” said Glenn Tracey, Microsaic CEO. “As far as I am aware, there is no other solution which combines such an incredible LC/MS offering into one small footprint today.”
About Axcend
Axcend is a provider of innovative, hand-portable and high-performance liquid chromatography (HPLC) systems. These solutions allow scientists to deliver HPLC Anywhere® and provide dramatic improvements in portability, ease-of-operation, and rapid and convenient deployment, as well as coupling to other analytical systems.
About Microsaic Systems
Microsaic Systems plc (AIM:MSYS) is working with a range of established global life science OEM partners, distributors and research organizations to co-develop and commercialize new mass spectrometry solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision-making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors. For more information, please go to www.microsaic.com.
Axcend, the Axcend logo, Axcend Focus LC, and HPLC Anywhere are trademarks of Axcend, LLC. Microsaic and 4500 MiD are trademarks of Microsaic Systems plc. All other trademarks are property of their respective owners.
AXCEND CONTACT: |
|
David Politis, 801-556-8184, David.Politis@AxcendCorp.com |
|
MICROSAIC CONTACTS: |
|
Glenn Tracey, CEO (Microsaic Systems plc) |
+44 (0) 1483 751 577 |
Bevan Metcalf, FD |
|
N+1 Singer (Nominated Adviser & Broker) |
+44 (0) 20 7496 3000 |
Aubrey Powell / George Tzimas (Corporate Finance) |
|
Tom Salvesen (Corporate Broking) |
|
IFC Advisory Ltd (Financial PR) |
+44 (0) 20 3934 6630 |
Graham Herring |
|
Florence Chandler |
View original content to download multimedia:http://www.prnewswire.com/news-releases/axcend-and-microsaic-systems-enter-a-worldwide-integration-and-joint-marketing-and-sales-agreement-301012602.html
SOURCE Axcend
Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the…
LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of…
TUCSON, Ariz., Dec. 27, 2024 (GLOBE NEWSWIRE) -- via IBN – WEED Inc. (OTCQB: BUDZ), (“WEED,”…
STAMFORD, Conn., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Company”),…
VYVDURA® now approved for at-home self-injection in Japan for both generalized myasthenia gravis and CIDP…
Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (the…